{"id":"W2978840913","doi":"10.1016/j.molmet.2019.09.010","title":"Glucagon-like peptide 1 (GLP-1)","year":2019,"lang":"en","type":"review","venue":"Molecular Metabolism","topic":"Diabetes Treatment and Management","field":"Medicine","cited_by":1738,"is_retracted":false,"has_abstract":true,"ca_institutions":"Lunenfeld-Tanenbaum Research Institute; University of Toronto","funders":"European Research Council; BERLIN-CHEMIE; Canadian Institutes of Health Research; Merck Sharp and Dohme; Medical Research Council; Johnson and Johnson; Servier; Novo Nordisk; National Institute for Health and Care Research; Novo Nordisk Fonden; Deutsche Forschungsgemeinschaft; Zafgen; Indiana University; Banting and Best Diabetes Centre, University of Toronto; Wellcome Trust; Alexander von Humboldt-Stiftung; Novartis Pharma; Helmholtz Association; Novartis; Merck KGaA; National Institute of Diabetes and Digestive and Kidney Diseases; Sanofi; Merck; Pfizer; AstraZeneca; Eli Lilly and Company; Boehringer Ingelheim","keywords":"Glucagon-like peptide-1; Glucagon-like peptide-2; Glucagon; Proglucagon; Incretin; Peptide; Chemistry; Internal medicine; Diabetes mellitus; Endocrinology; Medicine; Insulin; Biochemistry; Type 2 diabetes","routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002504672,0.0005931906,0.0005062912,0.000720239,0.0001273733,0.0006116352,0.0003350925,0.0004451121,0.004492456],"category_scores_gemma":[0.0003322791,0.00008083718,0.00029349,0.001010537,0.0002288669,0.0005070255,0.000513449,0.001165101,0.002332018],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0003041959,"about_ca_system_score_gemma":0.0005848057,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000451791,"about_ca_topic_score_gemma":0.0004029409,"domain_scores_codex":[0.9999158,0.00001335474,0.00000828205,0.00001793636,0.00003293591,0.00001170847],"domain_scores_gemma":[0.999921,0.0000263358,0.00001868354,0.000002759538,0.00002005518,0.00001119862],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.00009465242,0.00003274296,0.0001706765,0.009691774,0.00005814041,0.000130936,0.00003066158,0.0002184162,0.002914448,0.003512083,0.02748012,0.9556653],"study_design_scores_gemma":[0.00001957872,0.00008795804,0.0008322512,0.002653966,0.00007385678,0.00101261,0.00003832633,0.00006113257,0.0008668263,0.0022348,0.9921055,0.00001326239],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.0003866597,0.9945432,0.0003277718,0.0007190539,0.000466313,0.000006918451,0.00006354837,0.00002347487,0.003463126],"genre_scores_gemma":[0.003061771,0.9941754,0.0003899306,0.0004930078,0.0003647479,0.000009559535,0.0001013477,0.000003354142,0.001400971],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.004492456,"threshold_uncertainty_score":0.01502877,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.03531689130424301,"score_gpt":0.3185651192872342,"score_spread":0.2832482279829912,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}